What symptom do cannabinoids primarily target in cancer patients?

Cannabinoids primarily target nausea and vomiting in cancer patients, particularly as a result of chemotherapy treatments. They interact with cannabinoid receptors in the brain and gastrointestinal tract, which helps alleviate these distressing symptoms effectively. This is crucial for enhancing the quality of life for cancer patients, as nausea and vomiting can significantly hinder their ability to tolerate treatment regimens.

While cannabinoids can have effects on pain relief and appetite stimulation, their most notable and well-studied application in oncology has been in managing nausea and vomiting, particularly in cases where other antiemetics may not be effective. This targeting is a significant aspect of cannabinoid therapy in palliative care settings. Therefore, the primary symptom that cannabinoids address in cancer patients is indeed nausea and vomiting.